MyLeukemiaTeam

What is the prognosis for chronic myelomonocytic leukemia (CMML)?

The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:

Survival Rates by CMML Type
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About Show Full Answer

What is the prognosis for chronic myelomonocytic leukemia (CMML)?

The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:

Survival Rates by CMML Type:
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About 10 percent of people live for five years or more after diagnosis

Risk of Progression:
About 15 percent to 30 percent of people with CMML later develop acute myeloid leukemia (AML). The rate varies by subtype:
- Type 0 or 1 CMML: About 18 percent develop AML within five years
- Type 2 CMML: About 63 percent develop AML within five years

Factors That Influence Your Prognosis:
- Your age
- Whether you have other health conditions
- Your blood cell counts
- Which genetic changes your CMML cells have
- Your levels of lactate dehydrogenase (LDH)
- Your CMML subtype

Your healthcare team can help you understand how your individual characteristics affect your specific outlook with CMML.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Chronic Myelomonocytic Leukemia: An Overview